Generation of Human Bronchial Epithelial Cell Lines Expressing Inactive Mutants of GALNT3

Total Page:16

File Type:pdf, Size:1020Kb

Generation of Human Bronchial Epithelial Cell Lines Expressing Inactive Mutants of GALNT3 Advance Publication The Journal of Veterinary Medical Science Accepted Date: 29 May 2012 J-STAGE Advance Published Date: 12 Jun 2012 1 Virology Note 2 3 Generation of human bronchial epithelial cell lines expressing inactive mutants of 4 GALNT3 5 6 7 Shoko Nakamura1,2, Masayuki Horie1,¶, Kan Fujino1, Yusuke Matsumoto1, Tomoyuki Honda1, and 8 Keizo Tomonaga1,* 9 10 11 1Department of Viral Oncology, Institute for Virus Research, Kyoto University, Kyoto 606-8507, Japan. 12 2Department of Biomedical Informatics, Division of Health Sciences, Osaka University Graduate 13 School of Medicine, Suita, Osaka 565-0871, Japan. 14 15 Running Title: Inactive mutants of GALNT3 16 17 ¶Present address; Department of Virology, Institute for Medical Microbiology and Hygiene, University of 18 Freiburg, D-79104 Freiburg, Germany 19 20 *Corresponding author; Keizo Tomonaga; Department of Viral Oncology, Institute for Viral Research, 21 Kyoto University, Sakyo-ku Kyoto 606-8507, Japan. 22 Tel: +81-75-751-3997, Fax: +81-75-751-4000. E-mail: [email protected] 23 1 1 Abstract 2 3 As a tool to understand the role of mucins in the infection of respiratory viruses, we 4 established cell lines stably expressing inactive mutants of UDP-GalNAc:polypeptide 5 N-acetylgalactosaminlytransferase 3 (GALNT3), which initiates O-glycosylation of mucins. 6 We introduced single-amino-acid mutations into the regions essential for the enzyme activity 7 of GALNT3 using the expression plasmid of human GALNT3 and transfected the mutant 8 constructs into the human bronchial epithelial cell line, BEAS-2B. We showed that although 9 the mutants of GALNT3 exhibit an authentic localization at the Golgi apparatus, the 10 glycosylation pattern of the expressing cell lines is appeared to be different from that of the 11 cells expressing wild-type GALNT3. These results suggested that the established cell lines 12 express inactive forms of GALNT3 and might be useful to investigate the significance of 13 O-glycosylation of mucins in respiratory virus infections. 14 15 16 Key Words: GALNT3, Mucin, Respiratory viruses 2 1 2 Viral infections affecting the upper or lower respiratory tract, such as influenza virus, 3 parainfluenza virus, adenovirus and respiratory syncytial virus, commonly induce 4 characteristic alterations in the epithelial surfaces of the respiratory tract [2, 6, 13]. One of 5 such changes is the increased production of mucus [14]. The increased mucus in the 6 respiratory tract is believed to be involved in many characteristic clinical symptoms, as well 7 as the viral eliminations, at the early stage of the virus infections [8]. The mucus is largely 8 formed by mucins, which are complex O-linked glycosylated proteins. Recent studies 9 revealed that the expression of mucins increases in the epithelial cells both in vivo and in vitro 10 soon after some respiratory virus infections [9] and also that the upregulation of mucins may 11 play important roles for the host defense mechanism to virus infections [12]. However, the 12 detailed about how mucins are involved in the host defense mechanism have not yet been 13 elucidated. 14 The O-glycosylation of mucins is initiated by the transfer of GalNAc to serine and 15 threonine (Ser/Thr) residues on target polypeptides by a family of UDP-GalNAc:polypeptide 16 N-acetylgalactosaminlytransferase (GalNAc-T or GALNT). In human, the GALNT family 17 consists of twenty genes, which localize to different chromosomal loci. The genes have 18 different, but overlapping substrates and expression specificities [16]. Among them, GALNT3 19 is considered to mediate O-glycosylation of some mucins, including MUC1 and MUC2, as 20 well as the fibroblast growth factor 23 (FGF23), which is a bone-derived hormone that plays 21 an important role in the regulation of the metabolism of the phosphate and 1,25-dihydroxy 22 vitamin D [1, 7, 15]. Previous studies demonstrated that the expression of GALNT3 is seen in 23 several normal tissues, including the respiratory epithelium cells and bronchial glands cells 3 1 [3], showing suggestive roles of GALNT3 in respiratory virus infections. In this study, to 2 understand the roles of mucin-type O-glycosylation in the infection of respiratory viruses, we 3 tried to generate human bronchial epithelial cell lines expressing inactive mutants of 4 GALNT3. 5 To generate expression plasmid of human GALNT3, cDNA corresponding GLANT3 6 coding region was amplified from total RNA isolated from human alveolar basal epithelial 7 cells, A549, by PCR and cloned into the restriction enzyme sites (Kpn I and Not I) of the 8 pEF4 plasmid to yield pEF-hGALNT3. Detailed information about the primers and PCR 9 procedures used to generate the plasmid is available from the authors. Nucleotide sequence of 10 the recombinant plasmid was confirmed by DNA sequencing. To confirm the expression of 11 recombinant GALNT3, the plasmid was transfected into a human bronchial epithelial cell line, 12 BEAS-2B, and detected by anti-GALNT3 polyclonal antibody (SIGMA-Aldrich) (Fig. 2B, 13 see below). The inactive mutants of GALNT3 were constructed by introducing 14 single-amino-acid substitutions using pEF-hGALNT3. To predict the reactive residues within 15 GALNT3, we used information of earlier studies [4, 16, 17], in which the amino acid residues 16 responsible for the enzyme activity of murine and bovine GalNAc-T1 (GALNT1) were 17 determined. As the GALNT family is known to be highly homologues and the amino acid 18 residues essential for the enzyme activity seems to be significantly conserved among the 19 family [16], we introduced mutations in human GALNT3 in the sites corresponding to those 20 identified in murine and bovine GALNT1 (Fig. 1). In previous studies, some residues (mostly 21 histidines) were identified as essential for the enzyme activity of GALNT1 [4]. Among them, 22 mutants of aspartate and histidine at positions 209 and 211 of murine GALNT1, respectively, 4 1 consist of DxH motif, which was also described in many other glycosyltransferase, showed no 2 detectable enzyme activity [17]. In addition, a point mutation of histidine at position 344 was 3 shown to significantly decrease the activity of bovineGALNT1 [17]. Therefore, we introduced 4 the point mutations in the corresponding residues, D277, H279, and H415, of human 5 GALNT3 (Fig. 1). According to the previous studies, the aspartate and histidine residues were 6 changed to asparagine (D277N), aspartate (H279D), and alanine (H415A), respectively. The 7 mutant forms of the expression plasmid were generated using PCR amplification and 8 recloning or a PCR-based site-directed mutagenesis technique. Oligonucleotide primers and 9 PCR conditions to create the plasmids are available on request. Nucleotide sequences of the 10 recombinant constructs were also confirmed by DNA sequencing. 11 To generate cell clones stably expressing the GALNT3 mutants, we first tested the 12 susceptibility of BEAS-2B cells to the respiratory virus infection. The A/Puerto Rico/8/34 13 (PR8) strain of influenza A virus was inoculated into the parental BEAS-2B cell line at a 14 multiplicity of infection (MOI) of 3.0, and the infectivity was confirmed by indirect 15 immunofluorescence assay (IFA) using anti-nucleoprotein (NP) monoclonal antibody. As 16 shown in Fig. 2A, at 12 h postinfection, the parental BEAS-2B cells were shown to be 17 susceptible to influenza A virus. In addition, endogenous expression of GALNT3 was 18 undetectable in the parental BEAS-2B cells by both western blot analysis and IFA (Fig. 2B 19 and 2C), indicating that BEAS-2B cells are relevant for studying the role of GALNT3 in the 20 respiratory virus infection. 21 The mutant plasmids were transfected into BEAS-2B cells and, cell clones stably 22 expressing the wild-type and mutant GALNT3 were selected by 200 µg/ml Zeocin 5 1 (Invitrogen) in D-MEM (Dulbecco's Modified Eagle's Medium) (Nacalai tesque). We 2 obtained 4, 3, and 7 cell clones expressing D277N, H279D, and H415A mutants, respectively, 3 in which the expression level, as well as intracellular localization, of the mutant protein was 4 comparable to those of the wild-type GALNT3 (data not shown). Among them, we used a 5 representative clone in each mutant, and the expression of the mutant enzymes was verified 6 by western blotting and IFA using anti-GALNT3 polyclonal antibody (SIGMA-Aldrich). 7 Immunoblotting using 12% SDS-PAGE revealed that the mutants produce recombinant 8 proteins at the expected sizes (Fig. 2B). Previous studies revealed that the 9 glycosyltransferases commonly localize at the Golgi apparatus [11]. As shown in Fig. 2C, the 10 all mutants, D277N, H279D, and H415A, as well as the wild-type protein, exhibited a clear 11 distribution in the Golgi apparatus. These results indicated that the single-amino-acid 12 substitutions exert no effects on the expression and localization of GALNT3 in the transfected 13 cells. 14 We next investigated whether the GALNT3 mutants reduce its enzyme activity in the 15 cells. To this end, we performed lectin blot analysis using the lysates of BEAS-2B cell lines 16 stably expressing the wild-type and mutant GALNT3. Briefly, the cells were washed with 17 PBS and then lysed. Insoluble materials were removed by centrifugation, and equal amounts 18 of protein were separated using 12% SDS-PAGE and then transferred to nitrocellulose 19 membranes (Millipore). As a control of protein loading, we performed Coomassie Brilliant 20 Blue (CBB) staining using CBB Stain One (Nacalai tesque) (Fig. 3). For lectin blotting, 21 membranes were blocked with a Carbo-Free Blocking Solution (Vector Laboratories, Inc.) 22 and incubated with a different biotinylated lectin; 1.0 mg/ml PNA (Arachis hypogaea 6 1 agglutinin) (SIGMA-Aldrich) or 1.0 mg/ml ABA (Agaricus bisporus agglutinin) (Vector 2 Laboratries, Inc.) in Carbo-Free Blocking Solution for 1 h at room temperature.
Recommended publications
  • A Novel 65-Bp Indel in the GOLGB1 Gene Is Associated with Chicken Growth and Carcass Traits
    animals Article A Novel 65-bp Indel in the GOLGB1 Gene Is Associated with Chicken Growth and Carcass Traits Rong Fu 1,2, Tuanhui Ren 1,2, Wangyu Li 1,2, Jiaying Liang 1,2, Guodong Mo 1,2, Wen Luo 1,2, Danlin He 1,2, Shaodong Liang 1,2 and Xiquan Zhang 1,2,* 1 Department of Animal Genetics, Breeding and Reproduction, College of Animal Science, South China Agricultural University, Guangzhou 510642, China; [email protected] (R.F.); [email protected] (T.R.); [email protected] (W.L.); [email protected] (J.L.); [email protected] (G.M.); [email protected] (W.L.); [email protected] (D.H.); [email protected] (S.L.) 2 Guangdong Provincial Key Lab of Agro-Animal Genomics and Molecular Breeding, and Key Laboratory of Chicken Genetics, Breeding and Reproduction, Ministry of Agriculture, Guangzhou 510642, China * Correspondence: [email protected] Received: 20 February 2020; Accepted: 4 March 2020; Published: 12 March 2020 Simple Summary: Many Chinese-local chickens show slow-growing and low-producing performance, which is not conductive to the development of the poultry industry. The identification of thousands of indels in the last twenty years has helped us to make progress in animal genetics and breeding. Golgin subfamily B member 1 (GOLGB1) is located on chromosome 1 in chickens. Previous study showed that a large number of QTLs on the chicken chromosome 1 were related to the important economic traits. However, the biological function of GOLGB1 gene in chickens is still unclear. In this study, we detected a novel 65-bp indel in the fifth intron of the chicken GOLGB1 gene.
    [Show full text]
  • Viewed Previously [4]
    Barlow et al. BMC Biology (2018) 16:27 https://doi.org/10.1186/s12915-018-0492-9 RESEARCHARTICLE Open Access A sophisticated, differentiated Golgi in the ancestor of eukaryotes Lael D. Barlow1, Eva Nývltová2,3, Maria Aguilar1, Jan Tachezy2 and Joel B. Dacks1,4* Abstract Background: The Golgi apparatus is a central meeting point for the endocytic and exocytic systems in eukaryotic cells, and the organelle’s dysfunction results in human disease. Its characteristic morphology of multiple differentiated compartments organized into stacked flattened cisternae is one of the most recognizable features of modern eukaryotic cells, and yet how this is maintained is not well understood. The Golgi is also an ancient aspect of eukaryotes, but the extent and nature of its complexity in the ancestor of eukaryotes is unclear. Various proteins have roles in organizing the Golgi, chief among them being the golgins. Results: We address Golgi evolution by analyzing genome sequences from organisms which have lost stacked cisternae as a feature of their Golgi and those that have not. Using genomics and immunomicroscopy, we first identify Golgi in the anaerobic amoeba Mastigamoeba balamuthi. We then searched 87 genomes spanning eukaryotic diversity for presence of the most prominent proteins implicated in Golgi structure, focusing on golgins. We show some candidates as animal specific and others as ancestral to eukaryotes. Conclusions: None of the proteins examined show a phyletic distribution that correlates with the morphology of stacked cisternae, suggesting the possibility of stacking as an emergent property. Strikingly, however, the combination of golgins conserved among diverse eukaryotes allows for the most detailed reconstruction of the organelle to date, showing a sophisticated Golgi with differentiated compartments and trafficking pathways in the common eukaryotic ancestor.
    [Show full text]
  • Knock-Out of ACBD3 Leads to Dispersed Golgi Structure, but Unaffected Mitochondrial Functions in HEK293 and Hela Cells
    International Journal of Molecular Sciences Article Knock-Out of ACBD3 Leads to Dispersed Golgi Structure, but Unaffected Mitochondrial Functions in HEK293 and HeLa Cells Tereza Da ˇnhelovská 1 , Lucie Zdražilová 1 , Hana Štufková 1, Marie Vanišová 1, Nikol Volfová 1, Jana Kˇrížová 1 , OndˇrejKuda 2 , Jana Sládková 1 and Markéta Tesaˇrová 1,* 1 Department of Paediatrics and Inherited Metabolic Disorders, Charles University, First Faculty of Medicine and General University Hospital in Prague, 128 01 Prague, Czech Republic; [email protected] (T.D.); [email protected] (L.Z.); [email protected] (H.Š.); [email protected] (M.V.); [email protected] (N.V.); [email protected] (J.K.); [email protected] (J.S.) 2 Institute of Physiology, Academy of Sciences of the Czech Republic, 142 00 Prague, Czech Republic; [email protected] * Correspondence: [email protected] Abstract: The Acyl-CoA-binding domain-containing protein (ACBD3) plays multiple roles across the cell. Although generally associated with the Golgi apparatus, it operates also in mitochondria. In steroidogenic cells, ACBD3 is an important part of a multiprotein complex transporting cholesterol into mitochondria. Balance in mitochondrial cholesterol is essential for proper mitochondrial protein biosynthesis, among others. We generated ACBD3 knock-out (ACBD3-KO) HEK293 and HeLa cells and characterized the impact of protein absence on mitochondria, Golgi, and lipid profile. In ACBD3- Citation: Daˇnhelovská,T.; KO cells, cholesterol level and mitochondrial structure and functions are not altered, demonstrating Zdražilová, L.; Štufková, H.; that an alternative pathway of cholesterol transport into mitochondria exists. However, ACBD3- Vanišová, M.; Volfová, N.; Kˇrížová,J.; Kuda, O.; Sládková, J.; Tesaˇrová,M.
    [Show full text]
  • Signal Peptide Peptidase‐Like 2C Impairs Vesicular Transport And
    Article Signal peptide peptidase-like 2c impairs vesicular transport and cleaves SNARE proteins Alkmini A Papadopoulou1, Stephan A Müller2, Torben Mentrup3, Merav D Shmueli2,4,5, Johannes Niemeyer3, Martina Haug-Kröper1, Julia von Blume6, Artur Mayerhofer7, Regina Feederle2,8,9 , Bernd Schröder3,10 , Stefan F Lichtenthaler2,5,9 & Regina Fluhrer1,2,* Abstract Introduction Members of the GxGD-type intramembrane aspartyl proteases The high degree of compartmentalization in eukaryotic cells creates have emerged as key players not only in fundamental cellular a need for specific and precise protein trafficking. To meet this need, processes such as B-cell development or protein glycosylation, but cells have developed a complex system of vesicle transport that also in development of pathologies, such as Alzheimer’s disease or ensures safe sorting of cargo proteins, in particular between the dif- hepatitis virus infections. However, one member of this protease ferent compartments of the secretory pathway [1–3]. Vesicles origi- family, signal peptide peptidase-like 2c (SPPL2c), remains orphan nate from a donor membrane, translocate in a targeted manner, and and its capability of proteolysis as well as its physiological function get specifically tethered to the target membrane, before fusing with is still enigmatic. Here, we demonstrate that SPPL2c is catalytically it. Soluble N-ethylmaleimide-sensitive factor attachment protein active and identify a variety of SPPL2c candidate substrates using receptor (SNARE) proteins are known since three decades to medi- proteomics. The majority of the SPPL2c candidate substrates clus- ate specific membrane fusion [4,5]. So far, 38 SNARE proteins have ter to the biological process of vesicular trafficking.
    [Show full text]
  • The Murine Orthologue of the Golgi-Localized TPTE Protein Provides Clues to the Evolutionary History of the Human TPTE Gene Family
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by RERO DOC Digital Library Hum Genet (2001) 109:569–575 DOI 10.1007/s004390100607 ORIGINAL INVESTIGATION Michel Guipponi · Caroline Tapparel · Olivier Jousson · Nathalie Scamuffa · Christophe Mas · Colette Rossier · Pierre Hutter · Paolo Meda · Robert Lyle · Alexandre Reymond · Stylianos E. Antonarakis The murine orthologue of the Golgi-localized TPTE protein provides clues to the evolutionary history of the human TPTE gene family Received: 5 June 2001 / Accepted: 17 August 2001 / Published online: 27 October 2001 © Springer-Verlag 2001 Abstract The human TPTE gene encodes a testis-spe- events. The Y chromosome copy of TPTE is a pseudo- cific protein that contains four potential transmembrane gene and is not therefore involved in the testis expression domains and a protein tyrosine phosphatase motif, and of this gene family. shows homology to the tumor suppressor PTEN/MMAC1. Chromosomal mapping revealed multiple copies of the TPTE gene present on the acrocentric chromosomes 13, Introduction 15, 21 and 22, and the Y chromosome. Zooblot analysis suggests that mice may possess only one copy of TPTE. We have recently identified a testis-specific cDNA, TPTE In the present study, we report the isolation and initial (Transmembrane Phosphatase with TEnsin homology), characterization of the full-length cDNA of the mouse ho- that encodes a predicted protein of 551 amino acids con- mologue Tpte. At least three different mRNA transcripts taining four potential transmembrane domains and a tyro- (Tpte.a, b, c) are produced via alternative splicing, encod- sine phosphatase motif (Chen H et al.
    [Show full text]
  • Behavioral and Other Phenotypes in a Cytoplasmic Dynein Light Intermediate Chain 1 Mutant Mouse
    The Journal of Neuroscience, April 6, 2011 • 31(14):5483–5494 • 5483 Cellular/Molecular Behavioral and Other Phenotypes in a Cytoplasmic Dynein Light Intermediate Chain 1 Mutant Mouse Gareth T. Banks,1* Matilda A. Haas,5* Samantha Line,6 Hazel L. Shepherd,6 Mona AlQatari,7 Sammy Stewart,7 Ida Rishal,8 Amelia Philpott,9 Bernadett Kalmar,2 Anna Kuta,1 Michael Groves,3 Nicholas Parkinson,1 Abraham Acevedo-Arozena,10 Sebastian Brandner,3,4 David Bannerman,6 Linda Greensmith,2,4 Majid Hafezparast,9 Martin Koltzenburg,2,4,7 Robert Deacon,6 Mike Fainzilber,8 and Elizabeth M. C. Fisher1,4 1Department of Neurodegenerative Disease, 2Sobell Department of Motor Science and Movement Disorders, 3Division of Neuropathology, and 4Medical Research Council (MRC) Centre for Neuromuscular Diseases, University College London (UCL) Institute of Neurology, London WC1N 3BG, United Kingdom, 5MRC National Institute for Medical Research, London NW7 1AA, United Kingdom, 6Department of Experimental Psychology, University of Oxford, Oxford OX1 3UD, United Kingdom, 7UCL Institute of Child Health, London WC1N 1EH, United Kingdom, 8Department of Biological Chemistry, Weizmann Institute of Science, 76100 Rehovot, Israel, 9School of Life Sciences, University of Sussex, Brighton BN1 9QG, United Kingdom, and 10MRC Mammalian Genetics Unit, Harwell OX11 ORD, United Kingdom The cytoplasmic dynein complex is fundamentally important to all eukaryotic cells for transporting a variety of essential cargoes along microtubules within the cell. This complex also plays more specialized roles in neurons. The complex consists of 11 types of protein that interact with each other and with external adaptors, regulators and cargoes. Despite the importance of the cytoplasmic dynein complex, weknowcomparativelylittleoftherolesofeachcomponentprotein,andinmammalsfewmutantsexistthatallowustoexploretheeffects of defects in dynein-controlled processes in the context of the whole organism.
    [Show full text]
  • Multifaceted Polo-Like Kinases: Drug Targets and Antitargets for Cancer Therapy
    REVIEWS Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy Klaus Strebhardt Abstract | The polo-like kinase 1 (PLK1) acts in concert with cyclin-dependent kinase 1–cyclin B1 and Aurora kinases to orchestrate a wide range of critical cell cycle events. Because PLK1 has been preclinically validated as a cancer target, small-molecule inhibitors of PLK1 have become attractive candidates for anticancer drug development. Although the roles of the closely related PLK2, PLK3 and PLK4 in cancer are less well understood, there is evidence showing that PLK2 and PLK3 act as tumour suppressors through their functions in the p53 signalling network, which guards the cell against various stress signals. In this article, recent insights into the biology of PLKs will be reviewed, with an emphasis on their role in malignant transformation, and progress in the development of small-molecule PLK1 inhibitors will be examined. More than two decades ago polo, the founding member Early observations on the overexpression of PLK1 of the family of polo-like kinases (PLKs), was identified in human tumours12 and on the inhibition of cellu- as having an essential role in the ordered execution of lar proliferation by microinjecting antibodies against mitotic events in Drosophila melanogaster 1,2. Since the PLK1 into HeLa cells13 initiated a series of follow-on discovery of polo, a wealth of functional information on studies using a broad spectrum of inhibitors (for exam- PLKs has been collected in a wide phylogenetic space. ple, dominant-negative forms of PLK1, antisense oli- Five mammalian PLK family members have been iden- gonucleotides and small interfering RNAs) aiming to tified so far, PLK1 (also known as STPK13), PLK2 (also evaluate PLK1 as a potential target for the treatment known as SNK), PLK3 (also known as CNK, FNK and of cancer14–17.
    [Show full text]
  • Datasheet: MCA3923Z Product Details
    Datasheet: MCA3923Z Description: MOUSE ANTI HUMAN ACBD3:Preservative Free Specificity: ACBD3 Format: Preservative Free Product Type: Monoclonal Antibody Clone: 2G2 Isotype: IgG1 Quantity: 0.1 mg Product Details Applications This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit www.bio-rad-antibodies.com/protocols. Yes No Not Determined Suggested Dilution Immunohistology - Paraffin (1) 0.1 - 10 ug/ml Western Blotting Immunofluorescence 0.1 - 10 ug/ml Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using appropriate negative/positive controls. (1)This product requires antigen retrieval using heat treatment prior to staining of paraffin sections.Sodium citrate buffer pH 6.0 is recommended for this purpose. Target Species Human Species Cross Reacts with: Rat, Mouse Reactivity N.B. Antibody reactivity and working conditions may vary between species. Product Form Purified IgG - liquid Preparation Purified IgG prepared by affinity chromatography on Protein A Buffer Solution Phosphate buffered saline Preservative None present Stabilisers Approx. Protein Ig concentration 0.5 mg/ml Concentrations Immunogen Recombinant protein corresponding to aa 73-172 of human ACBD3 Page 1 of 3 External Database Links UniProt: Q9H3P7 Related reagents Entrez Gene: 64746 ACBD3 Related reagents Synonyms GCP60, GOCAP1, GOLPH1 Fusion Partners Spleen cells from immunised Balb/c mice were fused with cells from the Sp2/0 myeloma cell line.
    [Show full text]
  • Tyr198 Is the Essential Autophosphorylation Site for STK16 Localization and Kinase Activity
    International Journal of Molecular Sciences Article Tyr198 is the Essential Autophosphorylation Site for STK16 Localization and Kinase Activity 1,2, 3, 1 1,2,4, Junjun Wang y, Juanjuan Liu y, Xinmiao Ji and Xin Zhang * 1 High Magnetic Field Laboratory, Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China; [email protected] (J.W.); xinmiaoji@hmfl.ac.cn (X.J.) 2 Science Island Branch of Graduate School, University of Science and Technology of China, Hefei 230026, China 3 School of Life Sciences, Anhui University, Hefei 230601, China; [email protected] 4 Institutes of Physical Science and Information Technology, Anhui University, Hefei 230601, China * Correspondence: xinzhang@hmfl.ac.cn The authors contributed equally to this work. y Received: 27 August 2019; Accepted: 25 September 2019; Published: 30 September 2019 Abstract: STK16, reported as a Golgi localized serine/threonine kinase, has been shown to participate in multiple cellular processes, including the TGF-β signaling pathway, TGN protein secretion and sorting, as well as cell cycle and Golgi assembly regulation. However, the mechanisms of the regulation of its kinase activity remain underexplored. It was known that STK16 is autophosphorylated at Thr185, Ser197, and Tyr198 of the activation segment in its kinase domain. We found that STK16 localizes to the cell membrane and the Golgi throughout the cell cycle, but mutations in the auto-phosphorylation sites not only alter its subcellular localization but also affect its kinase activity. In particular, the Tyr198 mutation alone significantly reduced the kinase activity of STK16, abolished its Golgi and membrane localization, and affected the cell cycle progression.
    [Show full text]
  • Dlic1 Deficiency Impairs Ciliogenesis of Photoreceptors by Destabilizing Dynein
    Cell Research (2013) 23:835-850. © 2013 IBCB, SIBS, CAS All rights reserved 1001-0602/13 $ 32.00 npg ORIGINAL ARTICLE www.nature.com/cr Dlic1 deficiency impairs ciliogenesis of photoreceptors by destabilizing dynein Shanshan Kong1, Xinrong Du1, Chao Peng1, Yiming Wu1, Huirong Li2, Xi Jin2, Ling Hou2, Kejing Deng1, Tian Xu1, 3, Wufan Tao1 1State Key Laboratory of Genetic Engineering and Institute of Developmental Biology and Molecular Medicine, School of Life Sci- ence, Fudan University, Shanghai 200433, China; 2Developmental Cell Biology and Disease Program, State Key Laboratory Cul- tivation Base and Key Laboratory of Vision Science of Ministry of Health, Wenzhou Medical College, Wenzhou, Zhejiang 325003, China; 3Howard Hughes Medical Institute, Department of Genetics, Yale University School of Medicine, New Haven, CT 06536, USA Cytoplasmic dynein 1 is fundamentally important for transporting a variety of essential cargoes along microtu- bules within eukaryotic cells. However, in mammals, few mutants are available for studying the effects of defects in dynein-controlled processes in the context of the whole organism. Here, we deleted mouse Dlic1 gene encoding DLIC1, a subunit of the dynein complex. Dlic1−/− mice are viable, but display severe photoreceptor degeneration. Ab- lation of Dlic1 results in ectopic accumulation of outer segment (OS) proteins, and impairs OS growth and ciliogen- esis of photoreceptors by interfering with Rab11-vesicle trafficking and blocking efficient OS protein transport from Golgi to the basal body. Our studies show that Dlic1 deficiency partially blocks vesicle export from endoplasmic re- ticulum (ER), but seems not to affect vesicle transport from the ER to Golgi. Further mechanistic study reveals that lack of Dlic1 destabilizes dynein subunits and alters the normal subcellular distribution of dynein in photoreceptors, probably due to the impaired transport function of dynein.
    [Show full text]
  • 5 -Triphosphate RNA Requires Base-Paired Structures to Activate
    5؅-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I Andreas Schmidta,1, Tobias Schwerda,1, Wolfgang Hamma,1, Johannes C. Hellmutha, Sheng Cuib, Michael Wenzela, Franziska S. Hoffmanna, Marie-Cecile Michalletc, Robert Beschd, Karl-Peter Hopfnerb, Stefan Endresa, and Simon Rothenfussera,e,2 aDivision of Clinical Pharmacology, Department of Medicine, Ludwig-Maximilian University Munich, 80336 Munich, Germany; bCenter for Integrated Protein Sciences, Department of Chemistry and Biochemistry, Gene Center, Ludwig-Maximilian University Munich, 81377 Munich, Germany; dDepartment of Dermatology and Allergology and eSection Gastroenterology and Endocrinology, Medizinische Klinik Innenstadt, Ludwig-Maximilian University Munich, 80337 Munich, Germany; and cDepartment of Biochemistry, University of Lausanne, CH-1066 Epalinges, Switzerland Edited by Charles A. Dinarello, University of Colorado Health Sciences Center, Denver, CO, and approved May 26, 2009 (received for review January 29, 2009) The ATPase retinoid acid-inducible gene (RIG)-I senses viral RNA in the characterized as the structural entity that binds 5Ј-triphosphate and, cytoplasm of infected cells and subsequently activates cellular anti- thus, aids in defining ligand specificity (11, 12). However, the viral defense mechanisms. RIG-I recognizes molecular structures that concept that the 5Ј-triphosphate modification in cytosolic RNA discriminate viral from host RNA. Here, we show that RIG-I ligands represents the complete PAMP recognized by RIG-I
    [Show full text]
  • Giantin Knockout Models Reveal a Feedback Loop Between Golgi Function and Glycosyltransferase Expression
    bioRxiv preprint doi: https://doi.org/10.1101/123547; this version posted October 19, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Giantin knockout models reveal a feedback loop 2 between Golgi function and glycosyltransferase 3 expression 4 5 Nicola L. Stevenson1, Dylan J. M. Bergen1,2, Roderick E.H. Skinner2, Erika Kague2, Elizabeth 6 Martin-Silverstone2, Kate A. Robson Brown3, Chrissy L. Hammond2, and David J. Stephens1 * 7 8 1 Cell Biology Laboratories, School of Biochemistry, University of Bristol, Biomedical Sciences 9 Building, University Walk, Bristol, UK, BS8 1TD; 10 2 School of Physiology, Pharmacology and Neuroscience, University of Bristol, Biomedical Sciences 11 Building, University Walk, Bristol, UK, BS8 1TD; 12 3 Computed Tomography Laboratory, School of Arts, University of Bristol, 43 Woodland Road, Bristol 13 BS8 1UU 14 * Corresponding author and lead contact: [email protected] 15 Number of words: 5691 16 Summary statement: 17 Knockout of giantin in a genome-engineered cell line and zebrafish models reveals the capacity of 18 the Golgi to control its own biochemistry through changes in gene expression. 1 bioRxiv preprint doi: https://doi.org/10.1101/123547; this version posted October 19, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
    [Show full text]